UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by MRP Capital Investments LLC

MRP Capital Investments LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,108 shares of the healthcare conglomerate’s stock after selling 65 shares during the quarter. UnitedHealth Group accounts for approximately 1.4% of MRP Capital Investments LLC’s holdings, making the stock its 22nd largest position. MRP Capital Investments LLC’s holdings in UnitedHealth Group were worth $1,572,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 1.8 %

UnitedHealth Group stock opened at $512.30 on Friday. The business has a 50 day moving average price of $510.24 and a two-hundred day moving average price of $547.97. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $468.61 billion, a price-to-earnings ratio of 33.05, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.